腫瘤科（兒科）
止血的管理和優化
抗纖溶藥物
Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies. （開啟新視窗）
來源: Cancer 2013;119(21):3784-7.
檢索: PubMed 23921838
DOI碼: 10.1002/cncr.28253
Low dose bolus aminocaproic acid: an alternative to platelet transfusion in thrombocytopenia? （開啟新視窗）
來源: Eur J Haematol 1998;60(5):313-4.
檢索: PubMed 9654162
DOI碼: 10.1111/j.1600-0609.1998.tb01046.x
The use of antifibrinolytics in pediatric patients with hypoproliferative thrombocytopenia. （開啟新視窗）
來源: Pediatr Blood Cancer 2017;64(12):e26641.
檢索: PubMed 28544698
DOI碼: 10.1002/pbc.26641
Preliminary experience with epsilon aminocaproic acid for treatment of intractable upper tract hematuria in children with hematological disorders. （開啟新視窗）
來源: J Urol 2010;184(3):1152-7.
檢索: PubMed 20650477
DOI碼: 10.1016/j.juro.2010.05.020
A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia. （開啟新視窗）
來源: Leuk Lymphoma 1995;19(1-2):141-4.
檢索: PubMed 8574160
DOI碼: 10.3109/10428199509059668
重組活化凝血因子VII（rFVIIa）
Pediatric off-label use of recombinant factor VIIa. （開啟新視窗）
來源: Pediatrics 2009;123(3):1066-72.
檢索: PubMed 19255041
DOI碼: 10.1542/peds.2008-1685
Recombinant activated factor VII usage in life threatening hemorrhage: a pediatric experience. （開啟新視窗）
來源: Indian J Pediatr 2011;78(8):961-8.
檢索: PubMed 21328080
DOI碼: 10.1007/s12098-011-0364-6
Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated Factor VII. （開啟新視窗）
來源: Clin Appl Thromb Hemost 2005;11(4):401-10.
檢索: PubMed 16244765
Safety and efficacy of recombinant factor VIIa by pediatric age cohort: reassessment of compassionate use and trial data supporting US label. （開啟新視窗）
來源: Pediatr Blood Cancer 2016;63(10):1822-8.
檢索: PubMed 27232114
DOI碼: 10.1002/pbc.26082
Use of recombinant factor VIIa prior to lumbar puncture in pediatric patients with acute leukemia. （開啟新視窗）
來源: Pediatr Blood Cancer 2006;47(2):206-9.
檢索: PubMed 16007583
DOI碼: 10.1002/pbc.20467
A comprehensive review of rFVIIa use in a tertiary care pediatric center. （開啟新視窗）
來源: Pediatr Blood Cancer 2008;50(5):1013-7.
檢索: PubMed 17960639
DOI碼: 10.1002/pbc.21375
Recombinant activated factor VII for severe gastrointestinal bleeding after chemotherapy in an infant with acute megakaryoblastic leukemia. （開啟新視窗）
來源: Blood Coagul Fibrinolysis 2005;16(2):145-7.
檢索: PubMed 15741803
DOI碼: 10.1097/01.mbc.0000161569.66764.70
Off-label use of recombinant factor VIIa in pediatric patients. （開啟新視窗）
來源: Pediatrics 2012;129(6):e1533-40.
檢索: PubMed 22641758
DOI碼: 10.1542/peds.2011-2561
Dosing, efficacy, and safety of recombinant factor VIIa (rFVIIa) in pediatric versus adult patients: the experience of the Hemostasis and Thrombosis Research Society (HTRS) registry (2004-2008). （開啟新視窗）
來源: Pediatr Blood Cancer 2013;60(7):1178-83.
檢索: PubMed 23335449
DOI碼: 10.1002/pbc.24472
Successful treatment of severe gastrointestinal bleeding after chemotherapy in acute myeloblastic leukemia with recombinant activated factor VII: report on one case and review of other uses in acute leukemias. （開啟新視窗）
來源: Med Oncol 2010;27(1):16-9.
檢索: PubMed 19137431
DOI碼: 10.1007/s12032-008-9163-y
Successful treatment of acute lymphoblastic leukemia with l-asparaginase-induced intracranial hemorrhage to activated recombinant factor VIIa in a child. （開啟新視窗）
來源: Pediatr Hematol Oncol 2006;23(4):339-45.
檢索: PubMed 16621776
DOI碼: 10.1080/08880010600631987
Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. （開啟新視窗）
來源: Pediatr Hematol Oncol 2008;25(4):301-11.
檢索: PubMed 18484474
DOI碼: 10.1080/08880010802016904
去氨加壓素
The use of DDAVP in children with bleeding disorders. （開啟新視窗）
來源: Pediatr Blood Cancer 2013;60 Suppl 1:S41-3.
檢索: PubMed 23109357
DOI碼: 10.1002/pbc.24335
Treatment of refractory thrombocytopenic bleeding with 1-desamino-8-D-arginine vasopressin (desmopressin). （開啟新視窗）
來源: J Pediatr 1988;112(6):993-6.
檢索: PubMed 3373409
DOI碼: 10.1016/s0022-3476(88)80234-8
局部止血藥
The use of Tachosil as hemostatic sealant in nephron sparing surgery for Wilms tumor: preliminary observations. （開啟新視窗）
來源: J Pediatr Surg 2013;48(3):689-94.
檢索: PubMed 23480936
DOI碼: 10.1016/j.jpedsurg.2013.01.019